Comments
Loading...
NuCana (NASDAQ:NCNA) Stock Quotes, Forecast and News Summary
NuCana Stock (NASDAQ: NCNA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy NuCana (NCNA) stock?
You can purchase shares of NuCana (NASDAQ:NCNA) through any online brokerage.
Who are NuCana (NCNA) competitors?
Other companies in NuCana’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Quoin Pharmaceuticals (NASDAQ:QNRX) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
What is the forecast, or price target, for NuCana (NCNA) stock?
NuCana has a consensus price target of $11.33.
What is the current price for NuCana (NCNA)?
The stock price for NuCana (NASDAQ: NCNA) is $1.2633 last updated December 18, 2024 at 1:54 PM EST.
Does NuCana (NCNA) pay a dividend?
There are no upcoming dividends for NuCana.
When is NuCana (NASDAQ:NCNA) reporting earnings?
NuCana’s Q3 earnings are confirmed for Monday, November 25, 2024.
Is NuCana (NCNA) going to split?
There is no upcoming split for NuCana.
What sector and industry does NuCana (NCNA) operate in?
NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.